Atlas Trials

A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis

Clinical trial NCT02442570 · COMPLETED

Trial details

NCT number
NCT02442570
Sponsor
Delta Crystallon BV
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2012-09-01
Primary completion
2014-06-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.